Diagonal Bio is trading at 0.0338 as of the 24th of November 2024, a 3.05 percent increase since the beginning of the trading day. The stock's open price was 0.0328. Diagonal Bio has over 59 % chance of experiencing financial distress in the next 2 years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Diagonal Bio AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of November 2023 and ending today, the 24th of November 2024. Click here to learn more.
Although Diagonal Bio's alpha and beta are two of the key measurements used to evaluate Diagonal Bio's performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in Diagonal Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Sign In To Macroaxis Now
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Elected by the shareholders, the Diagonal Bio's board of directors comprises two types of representatives: Diagonal Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Diagonal. The board's role is to monitor Diagonal Bio's management team and ensure that shareholders' interests are well served. Diagonal Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Diagonal Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Diagonal Bio financial ratios help investors to determine whether Diagonal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diagonal with respect to the benefits of owning Diagonal Bio security.